Third dose of AstraZeneca is effective against omicron variant of Covid-19
The company said the findings “add to the growing body of evidence supporting Vaxzevria as a third-dose booster, regardless of the initial vaccination schedules run.”
The company said the findings “add to the growing body of evidence supporting Vaxzevria as a third-dose booster, regardless of the initial vaccination schedules run.”
